Neurodegenerative diseases
Neurodegenerative disease
http://www.ohsu.edu
Neurodegenerative Diseases and the Immune System
Jennifer Sohn
http://people.virginia.edu
Neurodegenerative Disorders
Greg Balko M.D.
http://www.med.wright.edu
Football players more likely to develop neurodegenerative disease, study finds
Nadia Kounang, CNN
http://www.econ.wayne.edu
Neurodegenerative Diseases
Gerianne R. Bliss, M.D.
Chuck Hensley, R.Ph.
http://cmsu2.ucmo.edu
Genetics of Neurodegenerative Diseases
http://hematology.im.wustl.
Neuroanatomy of Personality in Neurodegenerative Diseases
Christine M. Stanley etal
http://medschool2.ucsf.edu
Two neurodegenerative diseases
Henry Lester
http://www.its.caltech.edu
Gene Regulatory Networks and Neurodegenerative Diseases
Anne Chiaramello, Ph.D
http://www.gwumc.edu
Medicinal Properties of Venom Components
http://www.chem.wisc.edu
Nervous System II:
Development & Plasticity
Arvin Gouw
http://mcb.berkeley.edu
Olfactory Dysfunction and Disorders
Jing Shen, M.D.
Matthew Ryan, M.D.
http://www.utmb.edu
Prion Diseases = Transmissible Spongiform Encephalopathies (TSE)
http://www.cst.cmich.edu
Neurodegenerative Disorders
The Gene-Environment Interaction
http://chua2.fiu.edu
162 Published articles on Neurodegenerative diseases
1. ABSTRACT FROM A SYMPOSIUM ON 'NEURODEGENERATIVE DISEASE AND AGEING'
Br J Pharmacol. 1999 March; 126(Suppl): 323P.
2. Therapeutic induction of autophagy to modulate neurodegenerative disease progression
Warren E Hochfeld, Shirley Lee, David C Rubinsztein
Acta Pharmacol Sin. 2013 May; 34(5): 600–604. Published online 2013 February 4. doi: http://dx.doi.org/10.
3. Atypical Chédiak-Higashi syndrome with attenuated phenotype: three adult siblings homozygous for a novel LYST deletion and with neurodegenerative disease
James D Weisfeld-Adams, Lakshmi Mehta, Janet C Rucker, Francine R Dembitzer, Arnold Szporn, Fred D Lublin, Wendy J Introne, Vikas Bhambhani, Michael C Chicka, Catherine Cho
Orphanet J Rare Dis. 2013; 8: 46. Published online 2013 March 22. doi: http://dx.doi.org/10.
4. ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC
Jacqueline L. Blankman, Jonathan Z. Long, Sunia A. Trauger, Gary Siuzdak, Benjamin F. Cravatt
Proc Natl Acad Sci U S A. 2013 January 22; 110(4): 1500–1505. Published online 2013 January 7. doi: http://dx.doi.org/10.
5. NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks
Suhas V Vasaikar, Aditya K Padhi, Bhyravabhotla Jayaram, James Gomes
BMC Neurosci. 2013; 14: 3. Published online 2013 January 3. doi: http://dx.doi.org/10.
6. Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities
Sheila K. Pirooznia, Felice Elefant
Front Cell Neurosci. 2013; 7: 30. Published online 2013 March 28. doi: http://dx.doi.org/10.
7. The roles of fractalkine signaling in neurodegenerative disease
Bruce Lamb
Mol Neurodegener. 2012; 7(Suppl 1): L21. Published online 2012 February 7. doi: http://dx.doi.org/10.
8. Olfactory Dysfunction: Common in Later Life and Early Warning of Neurodegenerative Disease
Karl-Bernd Hüttenbrink, Thomas Hummel, Daniela Berg, Thomas Gasser, Antje Hähner
Dtsch Arztebl Int. 2013 January; 110(1-2): 1–7. Published online 2013 January 7. doi: http://dx.doi.org/10.
9. Launch of American Journal of Neurodegenerative Disease
Dennis W Dickson
Am J Neurodegener Dis. 2012; 1(1): i–ii. Published online 2012 May 30.
10. Endoplasmic Reticulum Stress and Parkinson's Disease: The Role of HRD1 in Averting Apoptosis in Neurodegenerative Disease
Tomohiro Omura, Masayuki Kaneko, Yasunobu Okuma, Kazuo Matsubara, Yasuyuki Nomura
Oxid Med Cell Longev. 2013; 2013: 239854. Published online 2013 April 18. doi: http://dx.doi.org/10.
11. Sleep disturbance in mental health problems and neurodegenerative disease
Kirstie N Anderson, Andrew J Bradley
Nat Sci Sleep. 2013; 5: 61–75. Published online 2013 May 31. doi: http://dx.doi.org/10.
12. A knowledge based approach to matching human neurodegenerative disease and animal models
Sarah M. Maynard, Christopher J. Mungall, Suzanna E. Lewis, Fahim T. Imam, Maryann E. Martone
Front Neuroinform. 2013; 7: 7. Published online 2013 May 14. doi: http://dx.doi.org/10.
13. Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling
Peter Reinhardt, Michael Glatza, Kathrin Hemmer, Yaroslav Tsytsyura, Cora S. Thiel, Susanne Höing, Sören Moritz, Juan A. Parga, Lydia Wagner, Jan M. Bruder, Guangming Wu, Benjamin Schmid, Albrecht Röpke, Jürgen Klingauf, Jens C. Schwamborn, Thomas Gasser, Hans R. Schöler, Jared Sterneckert
PLoS One. 2013; 8(3): e59252. Published online 2013 March 22. doi: http://dx.doi.org/10.
14. Crosstalk between the UPR and autophagy pathway contributes to handling cellular stress in neurodegenerative disease
René L. Vidal, Claudio Hetz
Autophagy. 2012 June 1; 8(6): 970–972. doi: http://dx.doi.org/10.
15. Menkes Kinky Hair Syndrome: A Rare Neurodegenerative Disease
Rozil Gandhi, Ritu Kakkar, Sajeev Rajan, Rashmi Bhangale, Shrinivas Desai
Case Rep Radiol. 2012; 2012: 684309. Published online 2012 August 7. doi: http://dx.doi.org/10.
16. Tau oligomers and tau toxicity in neurodegenerative disease
Sarah M. Ward, Diana S. Himmelstein, Jody K. Lancia, Lester I. Binder
Biochem Soc Trans. Author manuscript; available in PMC 2013 July 8.Published in final edited form as: Biochem Soc Trans. 2012 August; 40(4): 667–671. doi: http://dx.doi.org/10.
17. Schizophrenia or neurodegenerative disease prodrome? Outcome of a first psychotic episode in a 35-year old woman
Baber K. Khan, Josh D. Woolley, Steven Chao, Tricia See, Anna M. Karydas, Bruce L. Miller, Katherine P. Rankin
Psychosomatics. Author manuscript; available in PMC 2013 May 22.Published in final edited form as: Psychosomatics. 2012 May; 53(3): 280–284. Published online 2012 January 28. doi: http://dx.doi.org/10.
18. Neuroimaging in the early diagnosis of neurodegenerative disease
A Jon Stoessl
Transl Neurodegener. 2012; 1: 5. Published online 2012 January 13. doi: http://dx.doi.org/10.
19. The Emerging Science of BMAA: Do Cyanobacteria Contribute to Neurodegenerative Disease?
Wendee Holtcamp
Environ Health Perspect. 2012 March; 120(3): a110–a116. Published online 2012 March 1. doi: http://dx.doi.org/10.
20. Essential tremor is not a neurodegenerative disease
Ali H Rajput, Charles H Adler, Holly A Shill, Alex Rajput
Neurodegener Dis Manag. Author manuscript; available in PMC 2013 April 1.Published in final edited form as: Neurodegener Dis Manag. 2012 June; 2(3): 259–268. doi: http://dx.doi.org/10.
21. Establishment of Induced Pluripotent Stem Cells from Centenarians for Neurodegenerative Disease Research
Takuya Yagi, Arifumi Kosakai, Daisuke Ito, Yohei Okada, Wado Akamatsu, Yoshihiro Nihei, Akira Nabetani, Fuyuki Ishikawa, Yasumichi Arai, Nobuyoshi Hirose, Hideyuki Okano, Norihiro Suzuki
PLoS One. 2012; 7(7): e41572. Published online 2012 July 25. doi: http://dx.doi.org/10.
22. Epigenetic mechanisms in neurodevelopmental and neurodegenerative disease
Mira Jakovcevski, Schahram Akbarian
Nat Med. Author manuscript; available in PMC 2013 August 1.Published in final edited form as: Nat Med. 2012 August; 18(8): 1194–1204. doi: http://dx.doi.org/10.
23. Investigating the utility of human embryonic stem cell-derived neurons to model ageing and neurodegenerative disease using whole-genome gene expression and splicing analysis
Rickie Patani, Patrick A Lewis, Daniah Trabzuni, Clare A Puddifoot, David J A Wyllie, Robert Walker, Colin Smith, Giles E Hardingham, Michael Weale, John Hardy, Siddharthan Chandran, Mina Ryten
J Neurochem. 2012 August; 122(4): 738–751. doi: http://dx.doi.org/10.
24. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease
Oliver D. King, Aaron D. Gitler, James Shorter
Brain Res. Author manuscript; available in PMC 2013 June 26.Published in final edited form as: Brain Res. 2012 June 26; 1462: 61–80. Published online 2012 January 21. doi: http://dx.doi.org/10.
25. Cruel to Be Kind: Genomic Exacerbation of Lipid Defect in Yeast Suggests New Therapy for a Pediatric Neurodegenerative Disease♦: An “Exacerbate-reverse” Strategy in Yeast Identifies Histone Deacetylase Inhibition as a Correction for Cholesterol and Sphingolipid Transport Defects in Human Niemann-Pick Type C Disease
J Biol Chem. 2011 July 8; 286(27): e99953. doi: http://dx.doi.org/10.
26. American Journal of Neurodegenerative Disease: Editorial Board (2012) e-Century Publishing Corporation
Dennis W Dickson, Bruce L Miller, Bernardino Ghetti
Am J Neurodegener Dis. 2012; 1(1): 119–121. Published online 2012 May 23.
27. Why are the neurodegenerative disease-related pathways overrepresented in primary HIV-infected peripheral blood mononuclear cells: a genome-wide perspective
Li Zhou, Viviane Conceicao, Priyanka Gupta, Nitin K Saksena
Virol J. 2012; 9: 308. Published online 2012 December 16. doi: http://dx.doi.org/10.
28. Video Rating in Neurodegenerative Disease Clinical Trials: The Experience of PRION-1
Christopher Carswell, Michael Rañopa, Suvankar Pal, Rebecca MacFarlane, Durre Siddique, Dafydd Thomas, Tom Webb, Steve Wroe, Sarah Walker, Janet Darbyshire, John Collinge, Simon Mead, Peter Rudge
Dement Geriatr Cogn Dis Extra. 2012 Jan-Dec; 2(1): 286–297. Published online 2012 August 8. doi: http://dx.doi.org/10.
29. Stem Cells in Drug Screening for Neurodegenerative Disease
Hyun-Jung Kim, Chang Yun Jin
Korean J Physiol Pharmacol. 2012 February; 16(1): 1–9. Published online 2012 February 28. doi: http://dx.doi.org/10.
30. Role and Therapeutic Potential of the Pro-Longevity Factor FOXO and Its Regulators in Neurodegenerative Disease
Christian Neri
Front Pharmacol. 2012; 3: 15. Prepublished online 2012 January 9. Published online 2012 February 17. doi: http://dx.doi.org/10.
31. Neurodegenerative disease high-field imaging
M.J. Versluis, J. van der Grond, M.A. van Buchem, P. van Zijl, A.G. Webb
Neuroimaging Clin N Am. Author manuscript; available in PMC 2013 May 1.Published in final edited form as: Neuroimaging Clin N Am. 2012 May; 22(2): 159–ix. Published online 2012 March 31. doi: http://dx.doi.org/10.
32. Mitochondria, calcium-dependent neuronal death and neurodegenerative disease
Michael R. Duchen
Pflugers Arch. 2012 July; 464(1): 111–121. Published online 2012 May 22. doi: http://dx.doi.org/10.
33. The Role of p38 MAPK and Its Substrates in Neuronal Plasticity and Neurodegenerative Disease
Sônia A. L. Corrêa, Katherine L. Eales
J Signal Transduct. 2012; 2012: 649079. Published online 2012 June 25. doi: http://dx.doi.org/10.
34. The Neuroendocrine Protein 7B2 Suppresses the Aggregation of Neurodegenerative Disease-related Proteins
Michael Helwig, Akina Hoshino, Casey Berridge, Sang-Nam Lee, Nikolai Lorenzen, Daniel E. Otzen, Jason L. Eriksen, Iris Lindberg
J Biol Chem. 2013 January 11; 288(2): 1114–1124. Published online 2012 November 21. doi: http://dx.doi.org/10.
35. Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship
Brianne Magouirk Bettcher, Joel H. Kramer
Neurocase. Author manuscript; available in PMC 2013 August 5.Published in final edited form as: Neurocase. 2013 April; 19(2): 182–200. Published online 2012 April 19. doi: http://dx.doi.org/10.
36. Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Peter Kovacic, Ratnasamy Somanathan
Curr Neuropharmacol. 2012 December; 10(4): 289–302. Published online 2012 December. doi: http://dx.doi.org/10.
37. Lack of miRNA Misregulation at Early Pathological Stages in Drosophila Neurodegenerative Disease Models
Anita Reinhardt, Sébastien Feuillette, Marlène Cassar, Céline Callens, Hélène Thomassin, Serge Birman, Magalie Lecourtois, Christophe Antoniewski, Hervé Tricoire
Front Genet. 2012; 3: 226. Published online 2012 October 30. doi: http://dx.doi.org/10.
38. Intercellular (Mis)communication in Neurodegenerative Disease
Gwenn A. Garden, Albert R. La Spada
Neuron. Author manuscript; available in PMC 2013 March 8.Published in final edited form as: Neuron. 2012 March 8; 73(5): 886–901. doi: http://dx.doi.org/10.
39. Tau as a therapeutic target in neurodegenerative disease
Diana S. Himmelstein, Sarah M. Ward, Jody K. Lancia, Kristina R. Patterson, Lester I. Binder
Pharmacol Ther. Author manuscript; available in PMC 2013 July 1.Published in final edited form as: Pharmacol Ther. 2012 October; 136(1): 8–22. Published online 2012 July 10. doi: http://dx.doi.org/10.
40. BACE2 Expression Increases in Human Neurodegenerative Disease
Christopher J. Holler, Robin L. Webb, Ashley L. Laux, Tina L. Beckett, Dana M. Niedowicz, Rachel R. Ahmed, Yinxing Liu, Christopher R. Simmons, Amy L.S. Dowling, Angela Spinelli, Moshe Khurgel, Steven Estus, Elizabeth Head, Louis B. Hersh, M. Paul Murphy
Am J Pathol. 2012 January; 180(1): 337–350. doi: http://dx.doi.org/10.
41. Model Organisms Reveal Insight into Human Neurodegenerative Disease: Ataxin-2 Intermediate-Length Polyglutamine Expansions Are a Risk Factor for ALS
Nancy M. Bonini, Aaron D. Gitler
J Mol Neurosci. 2011 November; 45(3): 676–683. Published online 2011 June 10. doi: http://dx.doi.org/10.
42. Building An Integrated Neurodegenerative Disease Database At An Academic Health Center
Sharon X. Xie, Young Baek, Murray Grossman, Steven E. Arnold, Jason Karlawish, Andrew Siderowf, Howard Hurtig, Lauren Elman, Leo McCluskey, Vivianna Van Deerlin, Virginia M.-Y. Lee, John Q. Trojanowski
Alzheimers Dement. Author manuscript; available in PMC 2011 July 29.Published in final edited form as: Alzheimers Dement. 2011 July; 7(4): e84–e93. doi: http://dx.doi.org/10.
43. Air pollution & the brain: Subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease
Shannon Levesque, Michael J Surace, Jacob McDonald, Michelle L Block
J Neuroinflammation. 2011; 8: 105. Published online 2011 August 24. doi: http://dx.doi.org/10.
44. Structure of an Aprataxin–DNA complex with insights into AOA1 Neurodegenerative Disease
Percy Tumbale, C. Denise Appel, Rolf Kraehenbuehl, Patrick D. Robertson, Jessica S. Williams, Joe Krahn, Ivan Ahel, R. Scott Williams
Nat Struct Mol Biol. Author manuscript; available in PMC 2012 May 1.Published in final edited form as: Nat Struct Mol Biol. 2011 October 9; 18(11): 1189–1195. doi: http://dx.doi.org/10.
45. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease; rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease
Josh D. Woolley, Baber K. Khan, Nikhil K. Murthy, Bruce L. Miller, Katherine P. Rankin
J Clin Psychiatry. Author manuscript; available in PMC 2011 August 1.Published in final edited form as: J Clin Psychiatry. 2011 February; 72(2): 126–133. doi: http://dx.doi.org/10.
46. The Cycad Genotoxin MAM Modulates Brain Cellular Pathways Involved in Neurodegenerative Disease and Cancer in a DNA Damage-Linked Manner
Glen E. Kisby, Rebecca C. Fry, Michael R. Lasarev, Theodor K. Bammler, Richard P. Beyer, Mona Churchwell, Daniel R. Doerge, Lisiane B. Meira, Valerie S. Palmer, Ana-Luiza Ramos-Crawford, Xuefeng Ren, Robert C. Sullivan, Terrance J. Kavanagh, Leona D. Samson, Helmut Zarbl, Peter S. Spencer
PLoS One. 2011; 6(6): e20911. Published online 2011 June 23. doi: http://dx.doi.org/10.
47. Is Neurodegenerative Disease a Long-Latency Response to Early-Life Genotoxin Exposure?
Glen E. Kisby, Peter S. Spencer
Int J Environ Res Public Health. 2011 October; 8(10): 3889–3921. Published online 2011 September 29. doi: http://dx.doi.org/10.
48. Designing a Plan for Drug Discovery in Rare Pediatric Neurodegenerative Disease
Danielle Kerkovich, Amy Drew
Cerebrum. 2011 Jul-Aug; 2011: 11. Published online 2011 July 21.
49. Potential for Transcranial Laser or LED Therapy to Treat Stroke, Traumatic Brain Injury, and Neurodegenerative Disease
Margaret A. Naeser, Michael R. Hamblin
Photomed Laser Surg. 2011 July; 29(7): 443–446. doi: http://dx.doi.org/10.
50. Neurodegenerative disease biomarkers: Guideposts for disease prevention through early diagnosis and intervention
John Q. Trojanowski, Harald Hampel
Prog Neurobiol. Author manuscript; available in PMC 2013 February 18.Published in final edited form as: Prog Neurobiol. 2011 December; 95(4): 491–495. Published online 2011 July 23. doi: http://dx.doi.org/10.
51. Nanoparticles and Colloids as Contributing Factors in Neurodegenerative Disease
Stephen C. Bondy
Int J Environ Res Public Health. 2011 June; 8(6): 2200–2211. Published online 2011 June 14. doi: http://dx.doi.org/10.
52. Model Organisms Reveal Insight into Human Neurodegenerative Disease: Ataxin-2 Intermediate-Length Polyglutamine Expansions Are a Risk Factor for ALS
Nancy M. Bonini, Aaron D. Gitler
J Mol Neurosci. 2011 November; 45(3): 676–683. Published online 2011 June 10. doi: http://dx.doi.org/10.
53. A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome
Jie Ren, Anil G. Jegga, Minlu Zhang, Jingyuan Deng, Junbo Liu, Christopher B. Gordon, Bruce J. Aronow, Long J. Lu, Bo Zhang, Jun Ma
Hum Mol Genet. 2011 September 1; 20(17): 3424–3436. Published online 2011 June 8. doi: http://dx.doi.org/10.
54. Alexithymia in Neurodegenerative Disease
Virginia E. Sturm, Robert W. Levenson
Neurocase. Author manuscript; available in PMC 2012 February 13.Published in final edited form as: Neurocase. 2011 June; 17(3): 242–250. doi: http://dx.doi.org/10.
55. Neuropsychological correlates of dominance, warmth, and extraversion in neurodegenerative disease
Marc Sollberger, Christine M. Stanley, Robin Ketelle, Victoria Beckman, Matthew Growdon, Jung Jang, John Neuhaus, Joel H. Kramer, Bruce L. Miller, Katherine P. Rankin
Cortex. Author manuscript; available in PMC 2013 June 1.Published in final edited form as: Cortex. 2012 June; 48(6): 674–682. Published online 2011 March 10. doi: http://dx.doi.org/10.
56. A neurodegenerative disease mutation that accelerates the clearance of apoptotic cells
Aimee W. Kao, Robin J. Eisenhut, Lauren Herl Martens, Ayumi Nakamura, Anne Huang, Josh A. Bagley, Ping Zhou, Alberto de Luis, Lukas J. Neukomm, Juan Cabello, Robert V. Farese, Jr., Cynthia Kenyon
Proc Natl Acad Sci U S A. 2011 March 15; 108(11): 4441–4446. Published online 2011 February 28. doi: http://dx.doi.org/10.
57. Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease
Lise Munsie, Nicholas Caron, Randy Singh Atwal, Ian Marsden, Edward J. Wild, James R. Bamburg, Sarah J. Tabrizi, Ray Truant
Hum Mol Genet. 2011 May 15; 20(10): 1937–1951. Published online 2011 February 25. doi: http://dx.doi.org/10.
58. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease; rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease
Josh D. Woolley, Baber K. Khan, Nikhil K. Murthy, Bruce L. Miller, Katherine P. Rankin
J Clin Psychiatry. Author manuscript; available in PMC 2011 August 1.Published in final edited form as: J Clin Psychiatry. 2011 February; 72(2): 126–133. doi: http://dx.doi.org/10.
59. Alzheimer's Disease and Glaucoma: Imaging the Biomarkers of Neurodegenerative Disease
Denise A. Valenti
Int J Alzheimers Dis. 2010; 2010: 793931. Published online 2011 January 5. doi: http://dx.doi.org/10.
60. Prevalence Estimates for Latent Neurodegenerative Disease
Thomas J. Montine
Toxicol Pathol. Author manuscript; available in PMC 2012 January 1.Published in final edited form as: Toxicol Pathol. 2011; 39(1): 99–102. Published online 2010 December 21. doi: http://dx.doi.org/10.
61. Autophagy, inflammation and neurodegenerative disease
Mehrdad Alirezaei, Christopher C. Kemball, J. Lindsay Whitton
Eur J Neurosci. Author manuscript; available in PMC 2012 January 1.Published in final edited form as: Eur J Neurosci. 2011 January; 33(2): 197–204. Published online 2010 December 7. doi: http://dx.doi.org/10.
62. Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy
Ana G Barbeito, Thierry Levade, Marie B Delisle, Bernardino Ghetti, Ruben Vidal
Mol Neurodegener. 2010; 5: 50. Published online 2010 November 10. doi: http://dx.doi.org/10.
63. Mesenchymal stem cells for the treatment of neurodegenerative disease
Nanette Joyce, Geralyn Annett, Louisa Wirthlin, Scott Olson, Gerhard Bauer, Jan A Nolta
Regen Med. Author manuscript; available in PMC 2011 November 1.Published in final edited form as: Regen Med. 2010 November; 5(6): 933–946. doi: http://dx.doi.org/10.
64. Where Vascular meets Neurodegenerative Disease
JA Schneider, DA Bennett
Stroke. Author manuscript; available in PMC 2011 October 1.Published in final edited form as:
Stroke. 2010 October; 41(10 Suppl): S144–S146. doi: http://dx.doi.org/10.65. Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging
Yakup Batlevi, Albert R. La Spada
Neurobiol Dis. Author manuscript; available in PMC 2012 July 1.Published in final edited form as: Neurobiol Dis. 2011 July; 43(1): 46–51. Published online 2010 September 29. doi: http://dx.doi.org/10.
66. Mutations in ABHD12 Cause the Neurodegenerative Disease PHARC: An Inborn Error of Endocannabinoid Metabolism
Torunn Fiskerstrand, Dorra H'mida-Ben Brahim, Stefan Johansson, Abderrahim M'zahem, Bjørn Ivar Haukanes, Nathalie Drouot, Julian Zimmermann, Andrew J. Cole, Christian Vedeler, Cecilie Bredrup, Mirna Assoum, Meriem Tazir, Thomas Klockgether, Abdelmadjid Hamri, Vidar M. Steen, Helge Boman, Laurence A. Bindoff, Michel Koenig, Per M. Knappskog
Am J Hum Genet. 2010 September 10; 87(3): 410–417. doi: http://dx.doi.org/10.
67. Protein oxidative modifications in the aging brain: consequence for the onset of neurodegenerative disease
Stefanie Grimm, Annika Hoehn, Kelvin J. Davies, Tilman Grune
Free Radic Res. Author manuscript; available in PMC 2013 June 7.Published in final edited form as: Free Radic Res. 2011 January; 45(1): 73–88. Published online 2010 September 6. doi: http://dx.doi.org/10.
68. miR-107 Regulates Granulin/Progranulin with Implications for Traumatic Brain Injury and Neurodegenerative Disease
Wang-Xia Wang, Bernard R. Wilfred, Sindhu K. Madathil, Guiliang Tang, Yanling Hu, James Dimayuga, Arnold J. Stromberg, Qingwei Huang, Kathryn E. Saatman, Peter T. Nelson
Am J Pathol. 2010 July; 177(1): 334–345. doi: http://dx.doi.org/10.
69. Visual Spatial Cognition in Neurodegenerative Disease
Katherine L. Possin
Neurocase. Author manuscript; available in PMC 2011 December 1.Published in final edited form as: Neurocase. 2010 December; 16(6): 466–487. Published online 2010 June 2. doi: http://dx.doi.org/10.
70. The endocannabinoid system as a target for the treatment of neurodegenerative disease
Emma L Scotter, Mary E Abood, Michelle Glass
Br J Pharmacol. 2010 June; 160(3): 480–498. doi: http://dx.doi.org/10.
71. COGNITIVE DECLINE IN A DOG MODEL FOR AN INHERITED NEURODEGENERATIVE DISEASE USING T-MAZE PERFORMANCE
D.N. Sanders, S. Kanazono, J.R. Coates, G.S. Johnson, G.C. Johnson, K. Narfstrom, D.P. O’Brien, M.L. Katz
J Vet Behav. Author manuscript; available in PMC 2011 May 1.Published in final edited form as: J Vet Behav. 2010 May 1; 5(3): 154. doi: http://dx.doi.org/10.
72. Genetic determinants at the interface of cancer and neurodegenerative disease
LGT Morris, S Veeriah, TA Chan
Oncogene. Author manuscript; available in PMC 2011 June 17.Published in final edited form as: Oncogene. 2010 June 17; 29(24): 3453–3464. Published online 2010 April 26. doi: http://dx.doi.org/10.
73. Factors Affecting Survival of Patients with Neurodegenerative Disease
Kyle Steenland, Jessica MacNeil, Ryan Seals, Allan Levey
Neuroepidemiology. 2010 July; 35(1): 28–35. Published online 2010 April 8. doi: http://dx.doi.org/10.
74. Gray matter correlates of set-shifting among neurodegenerative disease, mild cognitive impairment, and healthy older adults
JUDY PA, KATHERINE L. POSSIN, STEPHEN M. WILSON, LOVINGLY C. QUITANIA, JOEL H. KRAMER, ADAM L. BOXER, MICHAEL W. WEINER, JULENE K. JOHNSON
J Int Neuropsychol Soc. Author manuscript; available in PMC 2010 July 1.Published in final edited form as: J Int Neuropsychol Soc. 2010 July; 16(4): 640–650. Published online 2010 April 7. doi: http://dx.doi.org/10.
75. TAR DNA-binding protein 43 in neurodegenerative disease
Alice S. Chen-Plotkin, Virginia M.-Y. Lee, John Q. Trojanowski
Nat Rev Neurol. Author manuscript; available in PMC 2010 June 25.Published in final edited form as: Nat Rev Neurol. 2010 April; 6(4): 211–220. Published online 2010 March 16. doi: http://dx.doi.org/10.
76. Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models
Jennifer I. Luebke, Christina M. Weaver, Anne B. Rocher, Alfredo Rodriguez, Johanna L. Crimins, Dara L. Dickstein, Susan L. Wearne, Patrick R. Hof
Brain Struct Funct. Author manuscript; available in PMC 2011 February 28.Published in final edited form as: Brain Struct Funct. 2010 March; 214(2-3): 181–199. Published online 2010 February 24. doi: http://dx.doi.org/10.
77. Sound Naming in Neurodegenerative Disease
Maggie L Chow, Simona M Brambati, Maria Luisa Gorno-Tempini, Bruce L Miller, Julene K Johnson
Brain Cogn. Author manuscript; available in PMC 2011 April 1.Published in final edited form as: Brain Cogn. 2010 April; 72(3): 423–429. Published online 2010 January 20. doi: http://dx.doi.org/10.
78. Modulation of Heat Shock Transcription Factor 1 as a Therapeutic Target for Small Molecule Intervention in Neurodegenerative Disease
Daniel W. Neef, Michelle L. Turski, Dennis J. Thiele
PLoS Biol. 2010 January; 8(1): e1000291. Published online 2010 January 19. doi: http://dx.doi.org/10.
79. Atrophy in two attention networks is associated with performance on a Flanker task in neurodegenerative disease
Tracy L. Luks, Michael Oliveira, Katherine L. Possin, Anne Bird, Bruce H. Miller, Michael W. Weiner, Joel H. Kramer
Neuropsychologia. Author manuscript; available in PMC 2011 January 10.Published in final edited form as: Neuropsychologia. 2010 January; 48(1): 165–170. doi: http://dx.doi.org/10.
80. Conceptual evolution in Alzheimer’s disease: Implications for understanding the clinical phenotype of progressive neurodegenerative disease
Gregory A. Jicha, Sarah A. Carr
J Alzheimers Dis. Author manuscript; available in PMC 2011 January 1.Published in final edited form as: J Alzheimers Dis. 2010 January; 19(1): 253–272. doi: http://dx.doi.org/10.
81. Minding Metals: Tailoring Multifunctional Chelating Agents for Neurodegenerative Disease
Lissette R. Perez, Katherine J. Franz
Dalton Trans. Author manuscript; available in PMC 2011 March 7.Published in final edited form as: Dalton Trans. 2010 March 7; 39(9): 2177–2187. Published online 2009 December 17. doi: http://dx.doi.org/10.
82. Neuroanatomical correlates of cognitive self-appraisal in neurodegenerative disease
Howard J. Rosen, Oscar Alcantar, Johannes Rothlind, Virginia Sturm, Joel H. Kramer, Michael Weiner, Bruce L. Miller
Neuroimage. Author manuscript; available in PMC 2010 February 15.Published in final edited form as: Neuroimage. 2010 February 15; 49(4): 3358. Published online 2009 December 1. doi: http://dx.doi.org/10.
83. Coenzyme Q10 effects in neurodegenerative disease
Meredith Spindler, M Flint Beal, Claire Henchcliffe
Neuropsychiatr Dis Treat. 2009; 5: 597–610. Published online 2009 November 16.
84. Detecting new neurodegenerative disease genes: does phenotype accuracy limit the horizon?
David C. Samuels, David J. Burn, Patrick F. Chinnery
Trends Genet. 2009 November; 25(11): 486–488. doi: http://dx.doi.org/10.
85. Four decades of neurodegenerative disease research: How far we have come!
Anne B. Young
J Neurosci. Author manuscript; available in PMC 2010 April 14.Published in final edited form as: J Neurosci. 2009 October 14; 29(41): 12722–12728. doi: http://dx.doi.org/10.
86. TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease
Tao Wang, Uyen Lao, Bruce A. Edgar
J Cell Biol. 2009 September 7; 186(5): 703–711. doi: http://dx.doi.org/10.
87. CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease?
Kavon Rezai-Zadeh, David Gate, Terrence Town
J Neuroimmune Pharmacol. 2009 December; 4(4): 462–475. Published online 2009 August 11. doi: http://dx.doi.org/10.
88. The Blood Brain Barrier in Neurodegenerative Disease: A Rhetorical Perspective
Paul M Carvey, Bill Hendey, Angela J. Monahan
J Neurochem. Author manuscript; available in PMC 2010 October 1.Published in final edited form as: J Neurochem. 2009 October; 111(2): 291–314. Published online 2009 July 31. doi: http://dx.doi.org/10.
89. A neurodegenerative disease affecting synaptic connections in Drosophila mutant for the tumor suppressor morphogen Patched
Michal Gazi, Baragur V. Shyamala, Krishna Moorthi Bhat
Dev Biol. Author manuscript; available in PMC 2010 October 1.Published in final edited form as: Dev Biol. 2009 October 1; 334(1): 311–323. Published online 2009 July 25. doi: http://dx.doi.org/10.
90. Subventricular Zone Neural Progenitors from Rapid Brain Autopsies of Elderly Subjects with and without Neurodegenerative Disease
Brian W. Leonard, Diego Mastroeni, Andrew Grover, Qiang Liu, Kechun Yang, Ming Gao, Jie Wu, David Pootrakul, Simone A. van den Berge, Elly M. Hol, Joseph Rogers
J Comp Neurol. Author manuscript; available in PMC 2010 July 20.Published in final edited form as: J Comp Neurol. 2009 July 20; 515(3): 269–294. doi: http://dx.doi.org/10.
91. Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates
Weiva Sieh, Yoonha Choi, Nicola H. Chapman, Ulla-Katrina Craig, Ellen J. Steinbart, Joseph H. Rothstein, Kiyomitsu Oyanagi, Ralph M. Garruto, Thomas D. Bird, Douglas R. Galasko, Gerard D. Schellenberg, Ellen M. Wijsman
Hum Mol Genet. 2009 October 1; 18(19): 3725–3738. Published online 2009 June 30. doi: http://dx.doi.org/10.
92. The basics of preclinical drug development for neurodegenerative disease indications
Karen L Steinmetz, Edward G Spack
BMC Neurol. 2009; 9(Suppl 1): S2. Published online 2009 June 12. doi: http://dx.doi.org/10.
93. Detecting Sarcasm from Paralinguistic Cues: Anatomic and Cognitive Correlates in Neurodegenerative Disease
Katherine P. Rankin, Andrea Salazar, Maria Luisa Gorno-Tempini, Marc Sollberger, Stephen M. Wilson, Danijela Pavlic, Christine M. Stanley, Shenly Glenn, Michael W. Weiner, Bruce L. Miller
Neuroimage. Author manuscript; available in PMC 2010 October 1.Published in final edited form as: Neuroimage. 2009 October 1; 47(4): 2005–2015. Published online 2009 June 6. doi: http://dx.doi.org/10.
94. Novel therapeutic strategies for neurodegenerative disease
Hitoshi TANIMUKAI, Takashi KUDO, Toshihisa TANAKA, Inge GRUNDKE-IQBAL, Khalid IQBAL, Masatoshi TAKEDA
Psychogeriatrics. Author manuscript; available in PMC 2011 July 19.Published in final edited form as: Psychogeriatrics. 2009 June; 9(2): 103–109. doi: http://dx.doi.org/10.
95. The neural correlates of verbal and non-verbal semantic processing deficits in neurodegenerative disease
Christopher R. Butler, Simona M. Brambati, Bruce L. Miller, Maria-Luisa Gorno-Tempini
Cogn Behav Neurol. Author manuscript; available in PMC 2010 June 1.Published in final edited form as: Cogn Behav Neurol. 2009 June; 22(2): 73–80. doi: http://dx.doi.org/10.
96. Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease
Yifeng Du, Michael C Wooten, Marie W. Wooten
Neurobiol Dis. Author manuscript; available in PMC 2010 August 1.Published in final edited form as: Neurobiol Dis. 2009 August; 35(2): 302–310. Published online 2009 May 28. doi: http://dx.doi.org/10.
97. An Image Driven Systems Biology Approach for Neurodegenerative Disease Studies in the TSC-mTOR Pathway
Dominik Beck, Xiaobo Zhou, Tuan Pham, Bernardo Sabatini, Stephen T.C. Wong
IEEE NIH Life Sci Syst Appl Workshop. Author manuscript; available in PMC 2011 September 13.Published in final edited form as: IEEE NIH Life Sci Syst Appl Workshop. 2009 May 2: : 36–39. doi: http://dx.doi.org/10.
98. Rule Violation Errors are Associated With Right Lateral Prefrontal Cortex Atrophy in Neurodegenerative Disease
Katherine L. Possin, Simona M. Brambati, Howard J. Rosen, Julene K. Johnson, Judy Pa, Michael W. Weiner, Bruce L. Miller, Joel H. Kramer
J Int Neuropsychol Soc. Author manuscript; available in PMC 2010 May 1.Published in final edited form as: J Int Neuropsychol Soc. 2009 May; 15(3): 354–364. doi: http://dx.doi.org/10.
99. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
R B. Postuma, J F. Gagnon, M Vendette, M L. Fantini, J Massicotte-Marquez, J Montplaisir
Neurology. 2009 April 14; 72(15): 1296–1300. doi: http://dx.doi.org/10.
100. Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1
Huda Y. Zoghbi, Harry T. Orr
J Biol Chem. 2009 March 20; 284(12): 7425–7429. doi: http://dx.doi.org/10.
101. Imaging Cerebral Blood Flow in the Cognitively Normal Aging Brain with Arterial Spin Labeling: Implications for Imaging of Neurodegenerative Disease
Charles Lee, Oscar L. Lopez, James T. Becker, Cyrus Raji, Weiying Dai, Lewis H. Kuller, H. Michael Gach
J Neuroimaging. Author manuscript; available in PMC 2009 October 2.Published in final edited form as: J Neuroimaging. 2009 October; 19(4): 344–352. Published online 2009 March 9. doi: http://dx.doi.org/10.
102. The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease
Marcus J. Calkins, Delinda A. Johnson, Jessica A. Townsend, Marcelo R. Vargas, James A. Dowell, Tracy P. Williamson, Andrew D. Kraft, Jong-Min Lee, Jiang Li, Jeffrey A. Johnson
Antioxid Redox Signal. 2009 March; 11(3): 497–508. doi: http://dx.doi.org/10.
103. Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative Disease
Colm Cunningham, Suzanne Campion, Katie Lunnon, Carol L. Murray, Jack F.C. Woods, Robert M.J. Deacon, J. Nicholas P. Rawlins, V. Hugh Perry
Biol Psychiatry. 2009 February 15; 65(4): 304–312. doi: http://dx.doi.org/10.
104. Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease
Asa Abeliovich, Claudia A. Doege
Neuron. Author manuscript; available in PMC 2013 May 21.Published in final edited form as: Neuron. 2009 February 12; 61(3): 337–339. doi: http://dx.doi.org/10.
105. The therapeutic importance of understanding mechanisms of neuronal cell death in neurodegenerative disease
Todd E Golde
Mol Neurodegener. 2009; 4: 8. Published online 2009 February 4. doi: http://dx.doi.org/10.
106. A novel NDUFA1 mutation leads to a progressive mitochondrial complex I- specific neurodegenerative disease
Prasanth Potluri, Antonio Davila, Eduardo Ruiz-Pesini, Dan Mishmar, Sean O'Hearn, Saege Hancock, Mariella Simon, Immo Scheffler, Douglas C. Wallace, Vincent Procaccio
Mol Genet Metab. Author manuscript; available in PMC 2010 April 1.Published in final edited form as: Mol Genet Metab. 2009 April; 96(4): 189–195. Published online 2009 January 29. doi: http://dx.doi.org/10.
107. Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics
Ling Lin, Timothy G. Lesnick, Demetrius M. Maraganore, Ole Isacson
Trends Neurosci. Author manuscript; available in PMC 2010 October 14.Published in final edited form as: Trends Neurosci. 2009 March; 32(3): 142–149. Published online 2009 January 21. doi: http://dx.doi.org/10.
108. The expanding realm of prion phenomena in neurodegenerative disease
Bess Frost, Marc I Diamond
Prion. 2009 Apr-Jun; 3(2): 74–77.
109. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
Leah R Hanson, William H Frey, II
BMC Neurosci. 2008; 9(Suppl 3): S5. Published online 2008 December 10. doi: http://dx.doi.org/10.
110. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
Melissa K McCoy, Malú G Tansey
J Neuroinflammation. 2008; 5: 45. Published online 2008 October 17. doi: http://dx.doi.org/10.
111. Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease
W. Michael Caudle, Sheng Pan, Min Shi, Thomas Quinn, Jake Hoekstra, Richard P. Beyer, Thomas J. Montine, Jing Zhang
Proteomics Clin Appl. Author manuscript; available in PMC 2011 July 25.Published in final edited form as: Proteomics Clin Appl. 2008 October; 2(10-11): 1484–1497. Published online 2008 September 10. doi: http://dx.doi.org/10.
112. Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice
Manik C. Ghosh, Wing-Hang Tong, Deliang Zhang, Hayden Ollivierre-Wilson, Anamika Singh, Murali C. Krishna, James B. Mitchell, Tracey A. Rouault
Proc Natl Acad Sci U S A. 2008 August 19; 105(33): 12028–12033. Published online 2008 August 6. doi: http://dx.doi.org/10.
113. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging
Richard I. Morimoto
Genes Dev. 2008 June 1; 22(11): 1427–1438. doi: http://dx.doi.org/10.
114. Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease
Rudy J. Castellani, Akihiko Nunomura, Raj K. Rolston, Paula I. Moreira, Atsushi Takeda, George Perry, Mark A. Smith
Int J Mol Sci. 2008 May; 9(5): 789–806. Published online 2008 May 20. doi: http://dx.doi.org/10.
115. Hijacking of the mismatch repair system to cause CAG expansion and cell death in neurodegenerative disease
Cynthia T. McMurray
DNA Repair (Amst) Author manuscript; available in PMC 2011 November 14.Published in final edited form as: DNA Repair (Amst). 2008 July 1; 7(7): 1121–1134. Published online 2008 May 9. doi: http://dx.doi.org/10.
116. Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states
Ronald L. Klein, Robert D. Dayton, Jason B. Tatom, Cynthia G. Diaczynsky, Michael F. Salvatore
Eur J Neurosci. Author manuscript; available in PMC 2010 November 8.Published in final edited form as: Eur J Neurosci. 2008 April; 27(7): 1615–1625. doi: http://dx.doi.org/10.
117. Harnessing the cell’s own ability to repair and prevent neurodegenerative disease
Harry Whelan, Kristina Desmet, Ellen Buchmann, Michele Henry, Margaret Wong-Riley, Janis Eells, James Verhoeve
SPIE Newsroom. Author manuscript; available in PMC 2009 February 18.Published in final edited form as: SPIE Newsroom. 2008 February 24; 2008: 1–3. doi: http://dx.doi.org/10.
118. Neurodegenerative disease: cleaning out Alzheimer’s by autophagy
Dis Model Mech. 2008 Jul-Aug; 1(1): 2.
119. Neurodegenerative disease: neurons don’t take all of the blame for ALS
Dis Model Mech. 2008 Jul-Aug; 1(1): 1.
120. Occupational exposures to magnetic fields and neurodegenerative disease risks
H Checkoway
Occup Environ Med. 2007 December; 64(12): 790–791. doi: http://dx.doi.org/10.
121. TDP-43 Immunoreactivity in Neurodegenerative Disease: Disease- versus Mechanism-Specificity
Dennis W. Dickson
Acta Neuropathol. Author manuscript; available in PMC 2009 June 1.Published in final edited form as: Acta Neuropathol. 2008 January; 115(1): 147–149. Published online 2007 November 23. doi: http://dx.doi.org/10.
122. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease
Maria Filimonenko, Susanne Stuffers, Camilla Raiborg, Ai Yamamoto, Lene Malerød, Elizabeth M.C. Fisher, Adrian Isaacs, Andreas Brech, Harald Stenmark, Anne Simonsen
J Cell Biol. 2007 November 5; 179(3): 485–500. doi: http://dx.doi.org/10.
123. Glial cells as intrinsic components of non-cell autonomous neurodegenerative disease
Christian S. Lobsiger, Don W. Cleveland
Nat Neurosci. Author manuscript; available in PMC 2011 June 7.Published in final edited form as: Nat Neurosci. 2007 November; 10(11): 1355–1360. doi: http://dx.doi.org/10.
124. Quantitative measurement of postural sway in mouse models of human neurodegenerative disease
Daniel Hutchinson, Venus Ho, Michael Dodd, Hana N. Dawson, Ann C. Zumwalt, Daniel Schmitt, Carol A. Colton
Neuroscience. Author manuscript; available in PMC 2008 January 7.Published in final edited form as: Neuroscience. 2007 September 21; 148(4): 825–832. Published online 2007 July 21. doi: http://dx.doi.org/10.
125. Muscle first in neurodegenerative disease?
Mitch Leslie
J Cell Biol. 2007 March 12; 176(6): 731. doi: http://dx.doi.org/10.
126. Brain Slices as Models for Neurodegenerative Disease and Screening Platforms to Identify Novel Therapeutics
Seongeun Cho, Andrew Wood, Mark R Bowlby
Curr Neuropharmacol. 2007 March; 5(1): 19–33.
127. INHIBITION OF MAPK AND STIMULATION OF AKT KINASE SIGNALING PATHWAYS: TWO APPROACHES WITH THERAPEUTIC POTENTIAL IN THE TREATMENT OF NEURODEGENERATIVE DISEASE
Robert E. Burke
Pharmacol Ther. Author manuscript; available in PMC 2007 September 5.Published in final edited form as: Pharmacol Ther. 2007 June; 114(3): 261–277. Published online 2007 February 27. doi: http://dx.doi.org/10.
128. Risperidone-Induced Neuroleptic Malignant Syndrome in Neurodegenerative Disease: A Case Report
Daniel Johnson, Aby Z. Philip, Dennis J. Joseph, Roy Varghese
Prim Care Companion J Clin Psychiatry. 2007; 9(3): 237–238.
129. Headliners: Neurodegenerative Disease: Inflammatory Enzyme Modulates Motor Neuron Damage in Amyotrophic Lateral Sclerosis
Jerry Phelps
Environ Health Perspect. 2006 December; 114(12): A697.
130. Structural anatomy of empathy in neurodegenerative disease
Katherine P. Rankin, Maria Luisa Gorno-Tempini, Stephen C. Allison, Christine M. Stanley, Shenly Glenn, Michael W. Weiner, Bruce L. Miller
Brain. Author manuscript; available in PMC 2008 October 7.Published in final edited form as: Brain. 2006 November; 129(Pt 11): 2945–2956. Published online 2006 September 28. doi: http://dx.doi.org/10.
131. Antisense oligonucleotide therapy for neurodegenerative disease
Richard A. Smith, Timothy M. Miller, Koji Yamanaka, Brett P. Monia, Thomas P. Condon, Gene Hung, Christian S. Lobsiger, Chris M. Ward, Melissa McAlonis-Downes, Hongbing Wei, Ed V. Wancewicz, C. Frank Bennett, Don W. Cleveland
J Clin Invest. 2006 August 1; 116(8): 2290–2296. Published online 2006 July 27. doi: http://dx.doi.org/10.
132. Signaling, Polyubiquitination, Trafficking, and Inclusions: Sequestosome 1/p62's Role in Neurodegenerative Disease
Marie W. Wooten, Xiao Hu, J. Ramesh Babu, M. Lamar Seibenhener, Thangiah Geetha, Michael G. Paine, Michael C. Wooten
J Biomed Biotechnol. 2006; 2006: 62079. Published online 2006 May 25. doi: http://dx.doi.org/10.
133. N-ACETYLASPARTATE AS A MARKER OF NEURONAL INJURY IN NEURODEGENERATIVE DISEASE
Norbert Schuff, Dieter J. Meyerhoff, Susanne Mueller, Linda Chao, Diana Truran Sacrey, Kenneth Laxer, Michael W. Weiner
Adv Exp Med Biol. Author manuscript; available in PMC 2007 January 19.Published in final edited form as: Adv Exp Med Biol. 2006; 576: 241–363.
134. Drosophila Models of Neurodegenerative Disease
Tzu-Kang Sang, George R. Jackson
NeuroRx. 2005 July; 2(3): 438–446.
135. The genetic epidemiology of neurodegenerative disease
Lars Bertram, Rudolph E. Tanzi
J Clin Invest. 2005 June 1; 115(6): 1449–1457. doi: http://dx.doi.org/10.
136. Early Environmental Origins of Neurodegenerative Disease in Later Life
Philip J. Landrigan, Babasaheb Sonawane, Robert N. Butler, Leonardo Trasande, Richard Callan, Daniel Droller
Environ Health Perspect. 2005 September; 113(9): 1230–1233. Published online 2005 May 26. doi: http://dx.doi.org/10.
137. Replaceable neurons and neurodegenerative disease share depressed UCHL1 levels
Anthony J. Lombardino, Xiao-Ching Li, Moritz Hertel, Fernando Nottebohm
Proc Natl Acad Sci U S A. 2005 May 31; 102(22): 8036–8041. Published online 2005 May 23. doi: http://dx.doi.org/10.
138. Comparison of Different Methodological Implementations of Voxel-Based Morphometry in Neurodegenerative Disease
Matthew L. Senjem, Jeffrey L. Gunter, Maria M. Shiung, Ronald C. Petersen, Clifford R. Jack, Jr.
Neuroimage. Author manuscript; available in PMC 2009 September 8.Published in final edited form as: Neuroimage. 2005 June; 26(2): 600–608. Published online 2005 April 12. doi: http://dx.doi.org/10.
139. SNP detection using peptide nucleic acid probes and conjugated polymers: Applications in neurodegenerative disease identification
Brent S. Gaylord, Michelle R. Massie, Stuart C. Feinstein, Guillermo C. Bazan
Proc Natl Acad Sci U S A. 2005 January 4; 102(1): 34–39. Published online 2004 December 23. doi: http://dx.doi.org/10.
140. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam
Susan J. Murch, Paul Alan Cox, Sandra Anne Banack
Proc Natl Acad Sci U S A. 2004 August 17; 101(33): 12228–12231. Published online 2004 August 4. doi: http://dx.doi.org/10.
141. A novel neurodegenerative disease characterised by posterior column ataxia and pyramidal tract involvement maps to chromosome 8p12–8q12.1
P Valdmanis, L Simoes, F Gros-Louis, J Stewart, G Rouleau, N Dupre
J Med Genet. 2004 August; 41(8): 634–639. doi: http://dx.doi.org/10.
142. Stem cell biology and neurodegenerative disease.
R D McKay
Philos Trans R Soc Lond B Biol Sci. 2004 May 29; 359(1445): 851–856. doi: http://dx.doi.org/10.
143. Biomarkers and Surrogate Outcomes in Neurodegenerative Disease: Lessons from Multiple Sclerosis
David H. Miller
NeuroRx. 2004 April; 1(2): 284–294.
144. Variations in neurodegenerative disease across the UK: findings from the national study of Progressive Intellectual and Neurological Deterioration (PIND)
G Devereux, L Stellitano, C Verity, A Nicoll, R Will, P Rogers
Arch Dis Child. 2004 January; 89(1): 8–12.
145. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam
Paul Alan Cox, Sandra Anne Banack, Susan J. Murch
Proc Natl Acad Sci U S A. 2003 November 11; 100(23): 13380–13383. doi: http://dx.doi.org/10.
146. Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease
Dulal Panda, Jonathan C. Samuel, Michelle Massie, Stuart C. Feinstein, Leslie Wilson
Proc Natl Acad Sci U S A. 2003 August 5; 100(16): 9548–9553. Published online 2003 July 28. doi: http://dx.doi.org/10.
147. Misfolded, protease-resistant proteins in animal models and human neurodegenerative disease
Dennis W. Dickson
J Clin Invest. 2002 November 15; 110(10): 1403–1405. doi: http://dx.doi.org/10.
148. Silent latency periods in methylmercury poisoning and in neurodegenerative disease.
Bernard Weiss, Thomas W Clarkson, William Simon
Environ Health Perspect. 2002 October; 110(Suppl 5): 851–854.
149. Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
Michael K. Lee, Wanda Stirling, Yanqun Xu, Xueying Xu, Dike Qui, Allen S. Mandir, Ted M. Dawson, Neal G. Copeland, Nancy A. Jenkins, Don L. Price
Proc Natl Acad Sci U S A. 2002 June 25; 99(13): 8968–8973. doi: http://dx.doi.org/10.
150. Episodic-like memory in animals: psychological criteria, neural mechanisms and the value of episodic-like tasks to investigate animal models of neurodegenerative disease.
R G Morris
Philos Trans R Soc Lond B Biol Sci. 2001 September 29; 356(1413): 1453–1465. doi: http://dx.doi.org/10.
151. The Fluorescent Congo Red Derivative, (Trans, Trans)−1-Bromo-2,5-Bis-(3-
Marie L. Schmidt, Theresa Schuck, Shelly Sheridan, Mei-Ping Kung, Hank Kung, Zhi-Ping Zhuang, Catherine Bergeron, Jacque S. Lamarche, Daniel Skovronsky, Benoit I. Giasson, Virginia M.-Y. Lee, John Q. Trojanowski
Am J Pathol. 2001 September; 159(3): 937–943.
152. What's bred in the nerves: discovering the gene for a rare neurodegenerative disease
David Helwig
CMAJ. 2000 June 13; 162(12): 1731.
153. Memory in Neurodegenerative Disease
C. GALTON
J Neurol Neurosurg Psychiatry. 1999 June; 66(6): 807.
154. ABSTRACT FROM A SYMPOSIUM ON 'NEURODEGENERATIVE DISEASE AND AGEING'
Br J Pharmacol. 1999 March; 126(Suppl): 323P.
155. Glutamine repeats as polar zippers: their role in inherited neurodegenerative disease.
M. F. Perutz
Mol Med. 1995 November; 1(7): 718–721.
156. Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus.
J L Portis, G J Spangrude, F J McAtee
J Virol. 1994 June; 68(6): 3879–3887. Correction in: J Virol. 1994 July; 68(7): 4706.
157. Chronic hypothermia and water intoxication associated with a neurodegenerative disease.
E. L. Corbett, S. Sisodiya, D. Sarkar
Postgrad Med J. 1993 December; 69(818): 937–940.
158. The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease.
J L Portis, S Perryman, F J McAtee
J Virol. 1991 April; 65(4): 1877–1883.
159. Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus.
J L Portis, S Czub, C F Garon, F J McAtee
J Virol. 1990 April; 64(4): 1648–1656.
160. The molecular mechanisms of scrapie encephalopathy and relevance to human neurodegenerative disease.
W J Lukiw, H J Cho, J C Kaufmann, D R Crapper McLachlan
Can J Vet Res. 1990 January; 54(1): 49–57.
161. Characterization of a progressive neurodegenerative disease induced by a temperature-sensitive Moloney murine leukemia virus infection.
J A Bilello, O M Pitts, P M Hoffman
J Virol. 1986 August; 59(2): 234–241.
162. Value of brain biopsy in neurodegenerative disease in childhood.
E Boltshauser, J Wilson
Arch Dis Child. 1976 April; 51(4): 264–268.
|
Bookmark this post:
|
|
Posts
0 comments:
Post a Comment